Fevertree Drinks saw its shares fizz upwards by nearly 24% after the revelation that North American beer behemoth Molson Coors has secured an 8.5% stake in the British premium mixer brand.
![]()
The $88 million (£69 million) deal not only marks a strategic equity play but also hands Molson Coors the exclusive rights to distribute and market Fevertree’s portfolio across the United States.
A tonic for Fevertree’s American expansion ambitions, this partnership has been lauded as a “game changer” by analysts at Jefferies. While 2025 is set to be a transitional year, with the company guiding for low single-digit revenue growth — implying a 3% cut to consensus expectations (£395m) and PHe (£400m) — expectations of double-digit gains by 2026 suggest that Fevertree is primed to effervesce in the U.S. market, fuelled by Molson Coors’ extensive distribution muscle.
The $88 million (£69 million) deal not only marks a strategic equity play but also hands Molson Coors the exclusive rights to distribute and market Fevertree’s portfolio across the United States.
A tonic for Fevertree’s American expansion ambitions, this partnership has been lauded as a “game changer” by analysts at Jefferies. While 2025 is set to be a transitional year, with the company guiding for low single-digit revenue growth — implying a 3% cut to consensus expectations (£395m) and PHe (£400m) — expectations of double-digit gains by 2026 suggest that Fevertree is primed to effervesce in the U.S. market, fuelled by Molson Coors’ extensive distribution muscle.